ELEVAI LABS announces the launch of its online E-commerce portal. The new E-commerce portal serves as a business-to-business extension of the Company’s existing B2B relationship with physician dispensed providers currently offering ELEVAI products in the $19.7 billion global industry. Through the Company’s online platform, retail customers can now select a physician provider to start their personalized skin care journey. Dr. Jordan Plews, CEO, expressed his enthusiasm, “As a physician-dispensed skincare line, ELEVAI believes that the purchase of ELEVAI Skincare products is best made through an authorized ELEVAI Skincare Professional. This reflects our commitment to our valued and carefully selected Dermatologists, Plastic Surgeons, and other Skincare Professionals with the medical knowledge and experience needed to guide patients on their skincare journey and maintain the fidelity of the brand.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ELAB:
- Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
- ELEVAI Labs Inc.: Stock Price Woes and Board Reshuffle
- ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
- Elevai Labs announces issuance of patent from USPTO
- Biotech Alert: Searches spiking for these stocks today